Transforming growth factor-β3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during Cl/Fr mouse lip fusion

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 73, Issue 12, 2005, Pages 956-965

  Muraoka, Noriko ^a   Shum, Lillian ^b   Fukumoto, Satoshi ^a   Nomura, Taisei ^c   Ohishi, Masamichi ^a   Nonaka, Kazuaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

CD31; CL Fraser mouse; Cleft lip; Cyclin D1; Flk 1; Mesenchymal cells; Serum free organ culture; TGF 3

Indexed keywords

CD31 ANTIGEN; CYCLIN D1; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; GENE EXPRESSION; LIP; MESENCHYME CELL; MORPHOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD31; CELL PROLIFERATION; CLEFT LIP; CYCLIN D1; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MESODERM; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN CULTURE TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA;

EID: 30344448285     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20191     Document Type: Article

References (37)

1. Amin N, Ohashi Y, Chiba J, et al. 1994. Alterations in vascular pattern of the developing palate in normal and spontaneous deft palate mouse embryos. Cleft Palate Craniofac J 31:332-344.
2. Ayadi A, Suelves M, Dolle P, Wasylyk B. 2001. Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech Dev 102:205-208.
3. Beverdam A, Brouwer A, Reijnen M, et al. 2001. Severe nasal clefting and abnormal embryonic apoptosis in Alx3/Alx4 double mutant mice. Development 128:3975-3986.
4. Bornstein S, Trasler DG, Fraser FC. 1970. Effect of the uterine environment on the frequency of spontaneous cleft lip in CL/FR mice. Teratology 3:295-298.
5. Brunet CL, Sharpe PM, Ferguson MW. 1995. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol 39:345-355.
6. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
7. Chimal-Monroy J, Diaz de Leon L. 1999. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int J Dev Biol 43:59-67,
8. Cobourne MT. 2004. The complex genetics of cleft lip and palate. Eur J Orthodont 26:7-16.
9. Cox DA. 1995. Transforming growth factor-beta 3. Cell Biol Int 19:357-371.
10. D'Angelo M, Greene RM. 1991. Transforming growth factor-beta modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate. Dev Biol 145:374-378.
11. D'Angelo M, Chen JM, Ugen K, Greene RM. 1994. TGF beta 1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J Exp Zool 270:189-201.
12. da Silva Filho OG, Ramos AL, Abdo RC. 1992. The influence of unilateral cleft lip and palate on maxillary dental arch morphology. Angle Orthodont 62:283-290.
13. da Silva Filho OG, Cristovao RM, Semb G. 1994. Prevalence of a soft tissue bridge in a sample of 2014 patients with complete unilateral clefts of the lip and palate. Cleft Palate Craniofac J 31:122-124.
14. Goumans MJ, Lebrin F, Valdimarsdottir G. 2003. Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways. Trends Cardiovasc Med 13:301-307.
15. Hosokawa R, Nonaka K, Moriruji M, et al. 2003. TGF-beta 3 decreases type I collagen and scarring after labioplasty. J Dent Res 82:558-564.
16. Jaskoll T, Melnick M. 1999. Submandibular gland morphogenesis: stage-specific expression of TGF-alpha /EGF, IGF, TGF-beta, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TGF-beta2, TGF-beta3, and EGF-r null mutations. Anat Rec 256:252-268.
17. Juriloff DM, Fraser FC. 1980. Genetic maternal effects on cleft lip frequency in A/J and CL/Fr mice. Teratology 21:167-175.
18. Kaartinen V, Haataja L, Nagy A, et al. 2002. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not suffident for epitheliomesenchymal transdifferentiation: implications for palatogenesis. Int J Mol Med 9:563-570.
19. Kim MH, Kim HJ, Choi JY, Nahm DS. 2003. Transforming growth factor-beta3 gene SfaN1 polymorphism in Korean nonsyndromic cleft lip and palate patients. J Biochem Mol Biol 36:533-537.
20. Kohama K, Nonaka K, Hosokawa R, et al. 2002. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res 81:688-694.
21. Lee SH, Fu KK, Hui JN, Richman JM. 2001. Noggin and retinoic acid transform the identity of avian facial prominences. Nature 414:909-912.
22. Linask KK, D'Angelo M, Gehris AL, Greene RM. 1991. Transforming growth factor-beta receptor profiles of human and murine embryonic palate mesenchymal cells. Exp Cell Res 192:1-9.
23. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. 2001. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294:559-563.
24. Mitchell JC, Wood RJ. 2000. Management of cleft lip and palate in primary care. J Pediatr Health Care 14:13-19.
25. Pepper MS. 1997. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43.
26. Pestell RG, Albanese C, Reutens AT, et al. 1999. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrinol Rev 20:501-534.
27. Redford-Badwal DA, Mabry K, Frassinelli JD. 2003. Impact of cleft lip and/or palate on nutritional health and oral-motor development. Dent Clin North Am 47:305-317.
28. Schuh AC, Faloon P, Hu QL, et al. 1999. In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc Natl Acad Sci U S A 96:2159-2164.
29. Seki Y, Suico MA, Uto A, et al. 2002. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Cancer Res 62:6579-6586.
30. Stark RB. 1954. The pathogenesis of harelip and cleft palate. Plast Reconstr Surg 13:20-39.
31. Taya Y, O'Kane S, Ferguson MW. 1999. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126:3869-3879.
32. Vieira AR, Orioli IM, Casrilla EE, et al. 2003. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res 82:289-292.
33. Wang KY, Juriloff DM, Diewert VM. 1995. Deficient and delayed primary palatal fusion and mesenchymal bridge formation in cleft lip-liable strains of mice. J Craniofac Genet Dev Biol 15:99-116.
34. Yamaguchi TP, Dumont DJ, Conlon RA, et al. 1993. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.
35. Yamamoto T, Cui XM, Shuler CF. 2003. Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion. Dev Biol 260:512-521.
36. Zhang Z, Song Y, Zhao X, et al. 2002. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development 129:4135-4146.
37. Zhu X, Scharf E, Assoian RK. 2000. Induction of anchorage-independent growth by transforming growth factor-beta linked to anchorage-independent expression of cyclin Dl. J Biol Chem 275:6703-6706.